Jinke shares (000656) 2019 first three quarter results pre-increasing comment: high performance, property management high-quality innovative shareholding plan escorted

Jinke shares (000656) 2019 first three quarter results pre-increasing comment: high performance, property management high-quality innovative shareholding plan escorted The 3rd quarter of 19 pre-annual growth of 64-83%, the settlement entered a bumper period, the high coverage of advance receipts


Jingfeng Pharmaceutical (000908) Commentary Report: New batch of methylprednisolone tablets and bivalirudin for injection are further enriched in the United States

Jingfeng Pharmaceutical (000908) Commentary Report: New batch of methylprednisolone tablets and bivalirudin for injection are further enriched in the United States Event: The company issued an announcement on June 28, 2019. The company’s holding subsidiary Sungen Pharma, LLC (hereinafter referred